PK modeling in BE [NCA / SHAM]

posted by mittyri  – Russia, 2020-07-19 02:24 (1816 d 20:38 ago) – Posting: # 21744
Views: 7,473

Hi Helmut,

❝ However, last year at the 10th American Conference on Pharmacometrics (20–23 October, Orlando) she gave a presentation “Evaluation of Model Based BioEquivalence (MBBE) statistical approaches for sparse designs PK studies” with a whoopy mean (!) Type I Error of 7.6%. :-(


Are you referring to this one?
Stan approach is a bit better, but still questionable

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,693 registered users;
53 visitors (0 registered, 53 guests [including 19 identified bots]).
Forum time: 23:02 CEST (Europe/Vienna)

If I’d observed all the rules,
I’d never have got anywhere.    Marilyn Monroe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5